@yourwelcome

Drug development: Raise standards for preclinical cancer research

, and . Nature, 483 (7391): 531--533 (March 2012)
DOI: 10.1038/483531a

Abstract

C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.

Links and resources

Tags